Chronic Lymphocytic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1447
|
291
|
0.100 |
None |
1.000 |
14 |
|
1999 |
2020 |
Multiple Sclerosis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
1800
|
1022
|
0.100 |
None |
1.000 |
10 |
|
2017 |
2019 |
Eosinophil count procedure
|
phenotype |
|
Laboratory Procedure
|
610
|
1144
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Multiple Sclerosis, Relapsing-Remitting
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
206
|
7
|
0.090 |
None |
1.000 |
9 |
|
2017 |
2019 |
Acute lymphocytic leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1293
|
222
|
0.040 |
None |
1.000 |
4 |
|
2006 |
2019 |
Graft-vs-Host Disease
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
447
|
25
|
0.040 |
None |
1.000 |
4 |
|
2004 |
2019 |
Encephalomyelitis
|
disease |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
865
|
7
|
0.040 |
None |
1.000 |
4 |
|
2015 |
2018 |
Idiopathic Hypereosinophilic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
43
|
5
|
0.040 |
None |
1.000 |
4 |
|
2010 |
2015 |
T-Cell Prolymphocytic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
52
|
4
|
0.030 |
None |
1.000 |
3 |
|
2002 |
2003 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.030 |
None |
1.000 |
3 |
|
2003 |
2008 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.030 |
None |
1.000 |
3 |
|
2006 |
2019 |
Autoimmune Diseases
|
group |
Immune System Diseases
|
Disease or Syndrome
|
1758
|
428
|
0.030 |
None |
1.000 |
3 |
|
2001 |
2017 |
Hematologic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
827
|
60
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2008 |
Multiple Myeloma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Neoplastic Process
|
1740
|
865
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2006 |
Thyroid Diseases
|
group |
Endocrine System Diseases
|
Disease or Syndrome
|
230
|
26
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
B-Cell Lymphomas
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1408
|
42
|
0.020 |
None |
1.000 |
2 |
|
1996 |
2019 |
Peripheral T-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
190
|
10
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2008 |
Mastocytosis, Systemic
|
disease |
Neoplasms; Immune System Diseases
|
Neoplastic Process
|
94
|
11
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2014 |
Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
1883
|
1172
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Multiple sclerosis relapse
|
disease |
|
Disease or Syndrome
|
19
|
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2017 |
B-CELL MALIGNANCY, LOW-GRADE
|
disease |
|
Neoplastic Process
|
350
|
19
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2017 |
Adult T-Cell Lymphoma/Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
540
|
11
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2013 |
Leukemia, T-Cell
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
457
|
10
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2013 |
Immunosuppression
|
disease |
|
Disease or Syndrome
|
632
|
9
|
0.020 |
None |
1.000 |
2 |
|
2004 |
2019 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2018 |